<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Overseas Drug Trials Come Under Scrutiny</title>
	<atom:link href="http://www.pharmalot.com/2008/12/overseas-drug-trials-come-under-scrutiny/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/12/overseas-drug-trials-come-under-scrutiny/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Thu, 18 Mar 2010 18:21:50 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Steve</title>
		<link>http://www.pharmalot.com/2008/12/overseas-drug-trials-come-under-scrutiny/#comment-383452</link>
		<dc:creator>Steve</dc:creator>
		<pubDate>Tue, 02 Dec 2008 13:18:30 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=18101#comment-383452</guid>
		<description>I know knocking the pharma industry sells newspapers and may be popular with Joe Public but isn't it time someone provided a more balanced view . . . in my experience over the past 20 yrs the quality of the clinical trial work done in India, Eastern Europe and Asia is at least as good as the US and W Europe - and often better.  Sure there are occasional mistakes and regrettable errors - and no-one is excusing these - but this needs to be kept in perpective as they happen at least as often here in the US and in W Europe as they do in RoW.  It is also well established that patients are better off when cared for in a  clinical trial setting - irrespective of what treatment they're on.  They get better access to medical professionals, the latest care and of course potentially beneficial treatments . . .

How about we give the indutry some of the credit they deserve . . . 90% of new drugs are developed by pharma and they have been responsible for innovations that have revolutionised medicine over the past 100 yrs or so.  Take organ transplantation . . . without the revolutionary immunosuppressant cyclosporin (which was discovered and developed by Sandoz - now Novartis) we wouldn't have a viable solid organ transplantation program - and many hundreds of thousands of patients w/wide would have died young instead of being able to live relatively happy and productive lives.  

Of course, the pharma indutry is not perfect and even one patient suffering as a result of a trial error is one too many . . . but let's get some balance into this debate instead of contantly focusing on the negatives . . .</description>
		<content:encoded><![CDATA[<p>I know knocking the pharma industry sells newspapers and may be popular with Joe Public but isn&#8217;t it time someone provided a more balanced view . . . in my experience over the past 20 yrs the quality of the clinical trial work done in India, Eastern Europe and Asia is at least as good as the US and W Europe - and often better.  Sure there are occasional mistakes and regrettable errors - and no-one is excusing these - but this needs to be kept in perpective as they happen at least as often here in the US and in W Europe as they do in RoW.  It is also well established that patients are better off when cared for in a  clinical trial setting - irrespective of what treatment they&#8217;re on.  They get better access to medical professionals, the latest care and of course potentially beneficial treatments . . .</p>
<p>How about we give the indutry some of the credit they deserve . . . 90% of new drugs are developed by pharma and they have been responsible for innovations that have revolutionised medicine over the past 100 yrs or so.  Take organ transplantation . . . without the revolutionary immunosuppressant cyclosporin (which was discovered and developed by Sandoz - now Novartis) we wouldn&#8217;t have a viable solid organ transplantation program - and many hundreds of thousands of patients w/wide would have died young instead of being able to live relatively happy and productive lives.  </p>
<p>Of course, the pharma indutry is not perfect and even one patient suffering as a result of a trial error is one too many . . . but let&#8217;s get some balance into this debate instead of contantly focusing on the negatives . . .</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Meg</title>
		<link>http://www.pharmalot.com/2008/12/overseas-drug-trials-come-under-scrutiny/#comment-383405</link>
		<dc:creator>Meg</dc:creator>
		<pubDate>Mon, 01 Dec 2008 20:29:52 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=18101#comment-383405</guid>
		<description>Just a continuation of John LeCarre's "The Constant Gardener"....</description>
		<content:encoded><![CDATA[<p>Just a continuation of John LeCarre&#8217;s &#8220;The Constant Gardener&#8221;&#8230;.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
